Medtronic MiniMed Infusion Pump Lawsuit
In November of 2019, Medtroinc’s MiniMed infusion pumps were subjected to a Class 1 recall by the FDA. “Class 1” is the agency’s most serious recall notice, and is reserved for products that have a reasonable chance of seriously hurting or killing users.
The Minimed pump’s recall stems from a defect in its retainer ring, which holds the patient’s insulin in place. The ring can become damaged or loose, causing the pump to read and administer incorrect dosages of insulin. This can lead to serious injuries and could potentially be fatal if not manually corrected. The recall applies to 600 Series MiniMed insulin pumps, including:
- Model 630 G (MMT-1715): Distributed and sold from September 2016 to October 2019
- Model 670 G (MMT 1780): Distributed and sold from June 2017 to August 2019
Medtronic, the pump’s manufacturer, has received thousands of complaints regarding these pumps.
Insulin pumps are supposed to make diabetes more easily manageable. When they malfunction or have defects, it runs counter to the point having one and can cause severe harm to patients. If you or someone you love lives with diabetes and was hurt because of a defective MiniMed insulin pump, you may be eligible for compensation from the device’s manufacturer. Take the quiz on this page to find out if you qualify.